Dr. V. Bryan Lawlis, Jr
Dr. V. Bryan Lawlis, Jr - President and CEO of Itero Biopharmaceuticals and Director at Biomarin Pharmaceutical, Geron, and Sutro Biopharmaceuticals - has been appointed to the Board of Directors at KaloBios.
“His extensive industry knowledge and drug development experience, especially in the manufacturing of therapeutic proteins and antibodies, will serve KaloBios well as we advance the development of our portfolio of proprietary, patient-targeted, monoclonal antibodies towards commercialization,”said David Pritchard, KaloBios’ CEO.